Modeling of transmitted x-ray intensity variation with sample thickness and solid fraction in glycine compacts

被引:13
作者
Cao, WJ
Mullarney, MP
Hancock, BC
Bates, S
Morris, KR
机构
[1] Purdue Univ, Dept Ind & Phys Pharm, W Lafayette, IN 47907 USA
[2] Pfizer Global Res & Dev, Groton, CT 06340 USA
[3] SSCI Inc, W Lafayette, IN 47906 USA
[4] Amgen Inc, Thousand Oaks, CA 91320 USA
关键词
X-ray powder diffractometry; mathematical model; solid dosage forms; tablet; compaction;
D O I
10.1002/jps.10480
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The previous paper in this series introduced an X-ray diffraction quantitation method for the polymorphic content in tablets made of pure components. Before the method could be transferred, further studies were required to explain the commonly observed X-ray intensity variation in analyzing compacts. The literature typically attributes the variation to partial amorphization under compression and/or to preferred orientation, without much viable explanation or compelling evidence. In this study, changes in intensity in compacts analyzed in transmission geometry were found to be primarily a function of sample thickness and solid fraction. A theoretical model was developed to describe the X-ray powder diffraction (XRPD) intensity as a function of solid fraction, mass absorption coefficient, and thickness. The model was tested on two sets of glycine compacts: one with varying thickness at constant solid fraction, and the other with various solid fractions at a given thickness. The results show that the model predicts the XRPD intensity at any given sample thickness and solid fraction. With this model, the intensity variation of compacts made under different compression conditions can be normalized, making the method transferable to various tablet geometries and facilitating the analysis over expected ranges of formulation and process variation. (C) 2003Wiley-Liss, Inc.
引用
收藏
页码:2345 / 2353
页数:9
相关论文
共 14 条
[1]   Quantitative determination of polymorphic composition in intact compacts by parallel-beam X-ray powder diffractometry [J].
Cao, WJ ;
Bates, S ;
Peck, GE ;
Wildfong, PLD ;
Qiu, ZH ;
Morris, KR .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2002, 30 (04) :1111-1119
[2]   Quantifying amorphous content of lactose using parallel beam X-ray powder diffraction and whole pattern fitting [J].
Chen, XM ;
Bates, S ;
Morris, KR .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2001, 26 (01) :63-72
[3]  
DALTON CR, 2000, AAPS IND IN
[4]  
FUKUOKA E, 1993, CHEM PHARM BULL, V41, P595
[5]  
FUKUOKA E, 1993, CHEM PHARM BULL, V41, P1636
[6]  
FUKUOKA E, 1993, CHEM PHARM BULL, V41, P1284
[7]  
HANCOCK BC, 1989, PHARM TECH, V41, P665
[8]  
JANKINS R, 1995, INTR XRAY POWDER DIF, P64
[9]   PRECISION NEUTRON-DIFFRACTION STRUCTURE DETERMINATION OF PROTEIN AND NUCLEIC-ACID COMPONENTS .3. CRYSTAL AND MOLECULAR STRUCTURE OF AMINO-ACID ALPHA-GLYCINE [J].
JONSSON, PG ;
KVICK, A .
ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL CRYSTALLOGRAPHY AND CRYSTAL CHEMISTRY, 1972, B 28 (06) :1827-&
[10]  
KLUG HP, 1974, XRAY DIFFRACTION PRO, P135